Literature DB >> 22582086

Differences in substance-related risk behavior between dual and triple diagnosed severely mentally ill adults.

Michelle Decoux Hampton1, Linda Chafetz, Carmen Portillo.   

Abstract

OBJECTIVES: The purpose of this study was to determine if differences exist between adults with dual and triple diagnoses with regard to substance-related risk behaviors.
METHODS: This secondary analysis was a cross-sectional study. There were 252 subjects with dual and triple diagnoses recruited from residential crisis programs in San Francisco. Using descriptive and logistic regression analyses, subjects in the two groups were compared with regard to demographic data, types of substances, and routes of administration used in the previous 30 days to determine risk for exposure and/or transmission of HIV/HCV.
RESULTS: When compared to the dual diagnosis group, subjects with triple diagnoses were four times more likely to have engaged in IDU (p=.001) and 2.6 times more likely to use amphetamines (p=.05). They also reported using more types of substances over the lifetime (p<.0001). But with regard to other risk behaviors such as alcohol use to intoxication and cocaine/crack use, there were no significant differences.
CONCLUSION: Though many substance-related risk behaviors occurred in both groups, adults with triple diagnoses were more likely to engage in IDU, amphetamine use, and to use more types of substances over the lifetime. This information has the potential to inform interventions that might prevent/reduce substance-related risk in this population.

Entities:  

Year:  2011        PMID: 22582086      PMCID: PMC3347481          DOI: 10.1080/17523281.2011.608374

Source DB:  PubMed          Journal:  Ment Health Subst Use        ISSN: 1752-3273


  32 in total

1.  Merseyside, the first harm reduction conferences, and the early history of harm reduction.

Authors:  Pat O'Hare
Journal:  Int J Drug Policy       Date:  2007-02-06

Review 2.  HIV/AIDS prevention: a model for educating the inpatient psychiatric population.

Authors:  F B Tate; D A Longo
Journal:  AIDS Patient Care STDS       Date:  2000-06       Impact factor: 5.078

3.  Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness.

Authors:  A P Johnson-Masotti; S D Pinkerton; J A Kelly; L Y Stevenson
Journal:  AIDS Care       Date:  2000-06

4.  Knowledge and risks of human immunodeficiency virus transmission among veterans with severe mental illness.

Authors:  Jennifer L Strauss; Hayden B Bosworth; Karen M Stechuchak; Keith M Meador; Marian I Butterfield
Journal:  Mil Med       Date:  2006-04       Impact factor: 1.437

Review 5.  Bipolar disorder and substance abuse.

Authors:  Frances R Levin; Grace Hennessy
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

6.  The impact of substance dependence on HIV sexual risk-reduction among men with severe mental illness.

Authors:  A Berkman; D J Pilowsky; P A Zybert; C-S Leu; N Sohler; E Susser
Journal:  AIDS Care       Date:  2005-07

7.  HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse.

Authors:  Christina S Meade; Fiona S Graff; Margaret L Griffin; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2007-09-11       Impact factor: 4.492

8.  Reducing risky sexual behavior and substance use among currently and formerly homeless adults living with HIV.

Authors:  Mary Jane Rotheram-Borus; Katherine Desmond; W Scott Comulada; Elizabeth Mayfield Arnold; Mallory Johnson
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

9.  "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.

Authors:  Lynne Leonard; Emily DeRubeis; Linda Pelude; Emily Medd; Nick Birkett; Joyce Seto
Journal:  Int J Drug Policy       Date:  2007-05-01

10.  Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness.

Authors:  Christina S Meade; Kathleen J Sikkema
Journal:  Community Ment Health J       Date:  2006-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.